International Cancer Genome Consortium

Name

International Cancer Genome Consortium

Legal name

International Cancer Genome Consortium

Website

https://icgc.org

Company type

Private

Operating status

Closed

Headcount range

1–10 employees

Short description

The International Cancer Genome Consortium is an international research consortium that coordinated large-scale cancer genome studies and is transitioning under ICGC ARGO to translate genomic knowledge into clinical applications for cancer researchers and genomic scientists worldwide.

Ownership category

akta.pro rank

Product category

Cancer Genomics Research

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA)

akta.pro secondary industry

Genomic & Multi-Omic Biomarkers (NGS panels, transcriptomics, proteomics, metabolomics) (HLAAAMAJ)

Keywords

• Cancer genomics research
• Genomic data sharing
• Cancer genome sequencing
• Translational oncology
• International research consortium

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations

Core offering

The International Cancer Genome Consortium coordinates large-scale, international cancer genome studies and provides researchers with access to comprehensive, standardized cancer genomic datasets. Its core deliverables are the ICGC Data Portal (decommissioned June 2024) and the newer ICGC ARGO platform, along with data access services for the ICGC 25K dataset and PCAWG (Pan-Cancer Analysis of Whole Genomes) data. The consortium serves cancer researchers and genomic scientists worldwide.

Differentiator

Problem solved

Functional benefit

Products and services

• ICGC Data Portal The ICGC Data Portal was the primary interactive web portal for accessing cancer genome data from the International Cancer Genome Consortium. It served cancer researchers and genomic scientists by providing centralized access to standardized cancer genomic datasets. The portal was officially closed in June 2024.
• ICGC ARGO (Accelerating Research in Genomic Oncology) The new phase of the International Cancer Genome Consortium focused on translating genomic knowledge into new approaches to improve outcomes for people affected by cancer. It serves cancer researchers and the broader oncology community seeking to bridge genomic research and clinical applications.
• ICGC 25K Data Access Data access service for authorized users to access the ICGC 25K dataset of 25,000 cancer genome sequences. Documentation is available through the ICGC ARGO platform to guide researchers through the data access process. Intended for cancer researchers and genomic scientists conducting cancer genome analysis studies.
• PCAWG Data (Pan-Cancer Analysis of Whole Genomes) Pan-cancer whole genome analysis dataset that remains available for authorized users through the decommissioned ICGC Data Portal's data releases. Intended for cancer genomics researchers performing pan-cancer whole genome analyses.

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Broad incumbents

• National Cancer Institute (NCI): NCI is the U.S. federal agency funding large-scale cancer research including TCGA and other genomics programs; it is a broader institutional incumbent that funds and shapes the cancer genomics ecosystem ICGC operates within.
• European Bioinformatics Institute (EMBL-EBI): EMBL-EBI hosts major open biological databases (e.g., ArrayExpress, Ensembl) and serves as a backbone infrastructure provider for genomics data, including data from cancer genomics projects comparable to ICGC.

Direct peers

• Genomics England: Genomics England operates large-scale genomic sequencing programs (notably the 100,000 Genomes Project) and provides controlled access to genomic data for research and clinical use, directly paralleling ICGC's cancer-focused data sharing model.
• cBioPortal for Cancer Genomics: cBioPortal is a widely used open-access platform for exploring cancer genomic datasets including TCGA and ICGC contributions, serving the same researcher audience with visualization and analysis of cancer genomics data.
• AACR Project GENIE: AACR Project GENIE is an international cancer genomics data sharing consortium aggregating clinical and genomic data from multiple institutions, directly comparable to ICGC's consortium-driven data sharing model.
• The Cancer Genome Atlas (TCGA): TCGA is a landmark NIH/NCI-led cancer genomics program that, like ICGC, generated large-scale multi-omic cancer datasets and established standards for cancer genome characterization. It is the most directly comparable peer in mission and scope.

Emerging players

• Human Cell Atlas: The Human Cell Atlas is a large-scale international consortium generating reference cellular maps for health and disease including cancer, sharing ICGC's consortium-based model for global data coordination.
• Wellcome Sanger Institute: The Wellcome Sanger Institute leads large-scale cancer and human genomics projects (e.g., the Cancer, Ageing and Somatic Mutation programme) and contributes cancer genomic data resources with overlapping researcher communities.

Market position

Customer concentration

• Xx.com/icgc_dcc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about International Cancer Genome Consortium